“I was very proud to have gotten this done,” Trump said at an afternoon news briefing, at which he took no questions. Trump introduced both rules again in July as executive orders, but legal experts questioned whether they went through proper rulemaking processes and said those questions left them particularly vulnerable to legal challenges. It is unclear whether the Biden administration would implement and uphold the rules or overturn them after being sworn in. ADThe pharmaceutical industry, which has already killed at least one significant Trump administration drug pricing rule in the courts, signaled that it would challenge the administration over the “most favored nations” rule. AD“With the final rebate rule, we are taking on a broken system and delivering big discounts directly to American patients,” Azar said in a statement.

Source: Washington Post November 20, 2020 23:22 UTC